Riskpilot← Back to searchSign inGet full accessDA VINCI KLINIKKEN AS
ASActiveOrg 921057849Tamburveien 5, 1406 SkiGeneral medical practice activities · NACE 8621Est. 20181 employees
Revenue 2024
NOK 5,2M
-2% vs 2023
EBITDA margin
35.7%
+70% vs 2023
Equity ratio
81.7%
Financial strength
Net profit 2024
NOK 1,4M
+75% vs 2023
| Revenue | NOK 5,2M | -2% |
| EBITDA | NOK 1,8M | +70% |
| Net profit | NOK 1,4M | +75% |
| Total assets | NOK 7,5M | +10% |
| Equity | NOK 6,1M | +30% |
| Employees | 1 | — |
Legal name
DA VINCI KLINIKKEN AS
Org number
921057849
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
26. juni 2018
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Allmennlegevirksomhet, fysikalsk medisin, manuell terapi, undervisning og rådgivning, kjøp og salg av artikler knyttet til virksomheten, samt annet som naturlig faller inn under dette.
Address
Tamburveien 5, 1406 Ski
Phone
+4791006639
Email
post@davinciklinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 350 | 4 994 | 4 882 | 5 286 | 5 161 |
| Staff expenses | −1 843 | −1 759 | −4 061 | −3 153 | −2 197 |
| EBITDA | 1 937 | 2 581 | −144 | 1 087 | 1 843 |
| Depreciation & amort. | −79 | −78 | −77 | −53 | −0 |
| EBIT | 1 858 | 2 503 | −221 | 1 034 | 1 843 |
| Net financials | 26 | −0 | −2 | −3 | −4 |
| Profit before tax | 1 884 | 2 503 | −223 | 1 031 | 1 838 |
| Tax | 408 | 551 | −49 | 232 | 439 |
| Net profit | 1 476 | 1 952 | −174 | 800 | 1 400 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 269 | 5 521 | 5 304 | 6 799 | 7 450 |
| Equity | 2 726 | 4 420 | 4 246 | 4 685 | 6 085 |
| Long-term debt | 1 645 | 0 | 0 | 0 | 150 |
| Short-term debt | 898 | 1 101 | 1 058 | 2 113 | 1 215 |
| Total debt | 2 543 | 1 101 | 1 058 | 2 113 | 1 365 |
EBITDA margin
35.7%
This company
15.8%
Market median
+126% vs market
20202024
Equity ratio
81.7%
This company
38.2%
Market median
+114% vs market
20202024
Return on equity
23.0%
This company
18.4%
Market median
+25% vs market
20202024
Net profit margin
27.1%
This company
8.1%
Market median
+235% vs market
20202024
Asset turnover
0.69×
This company
1.12×
Market median
-38% vs market
20202024
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CG Chief Executive Officer | Chief Executive Officer | 2018 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Leonardo Holding As
DA VINCI KLINIKKEN AS Board members of DA VINCI KLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christos Glavas | Chief Executive Officer | 0 companies |